Ryan Crowe | Investor Relations |
Leonard Schleifer | Chief Executive Officer |
George Yancopoulos | Co-Founder, President and Chief Scientific Officer |
Marion McCourt | Executive Vice President and Head of Commercial |
Bob Landry | Chief Financial Officer |
Mohit Bansal | Wells Fargo |
Robyn Karnauskas | Truist |
Tyler Van Buren | Cowen |
Terence Flynn | Morgan Stanley |
Christopher Raymond | Piper Sandler |
Brian Abrahams | RBC Capital Markets |
Salveen Richter | Goldman Sachs |
Akash Tewari | Jefferies |
Chris Schott | JPMorgan |
Eddie Hickman | Guggenheim Securities |
David Risinger | SVB Securities |
Hartaj Singh | Oppenheimer |
Carter Gould | Barclays |
Evan Seigerman | BMO |
Welcome to the Regeneron Pharmaceuticals First Quarter 2023 Earnings Conference Call. My name is Josh, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session. Please note that this conference is being recorded.